Studying what affects daily experiences in pulmonary fibrosis
Part of Lungs & breathing clinical trials.
This study looks at factors that shape how people with pulmonary fibrosis experience the clinical study process (and possibly care). It may help improve future studies and support for patients by understanding what helps or gets in the way.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 18 years old
- Have a diagnosis of pulmonary fibrosis
- Be able to understand the study and sign written consent
- Not be enrolled in another research study at the same time
- If you can become pregnant, have a negative pregnancy test before joining
- If you are lactating (breastfeeding), you may not be eligible
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study builds a community registry to learn about people affected by pulmonary fibrosis and related lung conditions, including patients, caregivers, and close family. By joining, you help researchers better understand needs and experiences in the real world.
This study looks at genetic differences in people with idiopathic pulmonary fibrosis (a lung scarring condition with no known cause). It may help researchers understand what influences the disease and guide future treatment options.
This study looks at how patients with pulmonary fibrosis (lung scarring) make decisions about stopping or continuing anti-fibrosis medications, especially if they have had side effects. It may help doctors and patients understand the best treatment choices.
This trial is for people with scarring lung disease (pulmonary fibrosis) in Ireland. It aims to better understand and care for the condition, especially in families. The study will look at medical data and may help improve diagnosis and treatment.
This study looks at the experiences of people living with pulmonary hypertension. It may help improve how this condition is managed and how studies like this are run.
This study is looking at people with Idiopathic Pulmonary Fibrosis (IPF), a type of lung scarring. Researchers will use medical records to see if they can better predict how the disease will progress over time.
Hear when a new Pulmonary Fibrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.